Letter to the Editor
Regarding the prognostic factors in patients with ALK-positive non-small cell lung cancer treated with crizotinib
Limei Hu1, Youjun Xie1, Hongying Zhao
Corresponding author
wanzhy196344@163.com
Corresponding author at: Department of Clinical Laboratory, The People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences, 6 Taoyuan Road, Nanning, Guangxi, China.
Corresponding author at: Department of Clinical Laboratory, The People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences, 6 Taoyuan Road, Nanning, Guangxi, China.
Department of Clinical Laboratory, The People's Hospital of Guangxi Zhuang Autonomous Region & Guangxi Academy of Medical Sciences, Nanning, Guangxi, China
Read
1771
Timeswas read the article
468
Total PDF
1303
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 December | 46 | 30 | 76 |
| 2024 November | 87 | 52 | 139 |
| 2024 October | 61 | 38 | 99 |
| 2024 September | 66 | 57 | 123 |
| 2024 August | 383 | 72 | 455 |
| 2024 July | 404 | 77 | 481 |
| 2024 June | 56 | 32 | 88 |
| 2024 May | 58 | 26 | 84 |
| 2024 April | 60 | 32 | 92 |
| 2024 March | 64 | 37 | 101 |
| 2024 February | 18 | 15 | 33 |
